What is the indication of doxorubicin?
Doxorubicin is also indicated for the treatment of cancers of the ovary, prostate, stomach, thyroid; small cell cancer of lung, liver; squamous cell cancer of head and neck; multiple myeloma, Hodgkin’s disease, lymphomas, acute lymphocytic leukemia (ALL), and acute myeloid leukemia (AML).
What is doxorubicin target?
Doxorubicin is a type of chemotherapy drug called an anthracycline. It slows or stops the growth of cancer cells by blocking an enzyme called topo isomerase 2. Cancer cells need this enzyme to divide and grow. You might have doxorubicin in combination with other chemotherapy drugs.
What is given with doxorubicin?
Doxorubicin injection is used together with other medicines to treat cancer of the blood, lymph system, bladder, breast, stomach, lungs, ovaries, thyroid, nerves, kidneys, bones, and soft tissues, including muscles and tendons. It may also be used to treat other kinds of cancer, as determined by your doctor.
What are the side effects of azacitidine?
Azacitidine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- nausea.
- vomiting.
- diarrhea.
- constipation.
- sores on the mouth or tongue.
- hemorrhoids.
- stomach pain or tenderness.
- heartburn.
Is thioguanine an immunosuppressant?
Azathioprine, 6-mercaptopurine, and 6-thioguanine are immunosuppressive drugs indicated in the prevention of graft rejection, and treatment of auto-immune disease or inflammatory bowel disease. Their anti-nucleotidic properties are also used for the treatment of acute leukaemia.
Is mercaptopurine an immunosuppressant?
Azathioprine and mercaptopurine belong to the group of drugs called immunosuppressants. The immune system is important for fighting infections, but sometimes immune cells attack the body’s own tissues and trigger chronic inflammation (like that found in IBD).
What is the difference between doxorubicin and daunorubicin?
Daunorubicin reached higher intracellular peak concentrations than doxorubicin, but the latter drug was retained much longer. The cell/plasma concentration ratio was higher for daunorubicin than for its reduced metabolite daunorubicinol. No doxorubicinol was found intracellularly.
How is daunorubicin administered?
Daunorubicin is given by intravenous injection (IV). The syringe needle is placed directly into the tubing of a freely flowing IV solution into a vein or central line and the drug is given over several minutes. There is no pill form of daunorubicin.